by Linda Faye Tidwell

Berlin Neuroscience Meeting 2018

Together with our partner institutions, members and friends we would like to welcome the new cohort of the ECN PhD fellows.

Read more … Berlin Neuroscience Meeting 2018

by Linda Faye Tidwell

Successful in the Cluster of Excellence funding line

Congratulations to all seven Clusters of Excellence of Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, and Charité – Universitätsmedizin Berlin

Read more … Successful in the Cluster of Excellence funding line

by Linda Faye Tidwell

NeuroCure will receive further funding

Outstanding Research in Berlin: Seven Clusters of Excellence approved in the Excellence Strategy

In the Excellence Strategy research competition run by the German federal and state governments, seven Clusters of Excellence of Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, and Charité – Universitätsmedizin Berlin have been adopted in total. Starting in 2019, the interdisciplinary research projects will be funded for seven years with up to ten million euros per annum, as declared in Bonn.

Read more … NeuroCure will receive further funding

by Linda Faye Tidwell

Freigeist Fellowship for Shimpei Ishiyama

Shimpei Ishiyama, postdoc in Michael Brecht's lab, has successfully applied for a Freigeist Fellowship (VW Stiftung). He will receive 1 Mio Euro to continue his research on positive emotions like ticklishness and their corresponding neuronal processes in the brain.

Read more … Freigeist Fellowship for Shimpei Ishiyama

by Linda Faye Tidwell

New FENS-Kavli Scholar

Susanne Schreiber, member of the Einstein Center for Neurosciences Berlin was elected as FENS-Kavli Scholar into the FENS-Kavli Network of Excellence.

Read more … New FENS-Kavli Scholar

by Linda Faye Tidwell

New generation of pain medications

Researchers from Charité – Universitätsmedizin Berlin and the Zuse-Institut Berlin have developed a new generation of pain medications. Using computer simulations, they have designed new opioids that have an effect only at the site of injury or inflammation

Read more … New generation of pain medications